BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 16930660)

  • 1. Treatment of snakebite in Australia: the current evidence base and questions requiring collaborative multicentre prospective studies.
    Currie BJ
    Toxicon; 2006 Dec; 48(7):941-56. PubMed ID: 16930660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12).
    Isbister GK; White J; Currie BJ; O'Leary MA; Brown SG;
    Toxicon; 2011 Dec; 58(8):634-40. PubMed ID: 21967812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum.
    Kulawickrama S; O'Leary MA; Hodgson WC; Brown SG; Jacoby T; Davern K; Isbister GK
    Toxicon; 2010 Jul; 55(8):1510-8. PubMed ID: 20223258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivenom efficacy or effectiveness: the Australian experience.
    Isbister GK
    Toxicology; 2010 Feb; 268(3):148-54. PubMed ID: 19782716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Western Australia over 10 years.
    Yeung JM; Little M; Murray LM; Jelinek GA; Daly FF
    Med J Aust; 2004 Dec 6-20; 181(11-12):703-5. PubMed ID: 15588174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bites in Australian snake handlers--Australian snakebite project (ASP-15).
    Isbister GK; Brown SG;
    QJM; 2012 Nov; 105(11):1089-95. PubMed ID: 22875778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming--Australian snakebite project (ASP-14).
    Allen GE; Brown SG; Buckley NA; O'Leary MA; Page CB; Currie BJ; White J; Isbister GK;
    PLoS One; 2012; 7(12):e53188. PubMed ID: 23300888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme immunoassays in brown snake (Pseudonaja spp.) envenoming: detecting venom, antivenom and venom-antivenom complexes.
    O'Leary MA; Isbister GK; Schneider JJ; Brown SG; Currie BJ
    Toxicon; 2006 Jul; 48(1):4-11. PubMed ID: 16764898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
    Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK;
    Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
    O'Leary MA; Isbister GK
    Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25).
    Johnston CI; Ryan NM; O'Leary MA; Brown SG; Isbister GK
    Clin Toxicol (Phila); 2017 Feb; 55(2):115-122. PubMed ID: 27903075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
    Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ;
    Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
    Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
    Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snakebite in Australia: a practical approach to diagnosis and treatment.
    Isbister GK; Brown SG; Page CB; McCoubrie DL; Greene SL; Buckley NA
    Med J Aust; 2013 Dec; 199(11):763-8. PubMed ID: 24329653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of pressure-immobilization first aid for snakebite requires further study.
    Currie BJ; Canale E; Isbister GK
    Emerg Med Australas; 2008 Jun; 20(3):267-70. PubMed ID: 18549384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific antivenom for Bungarus candidus.
    Leeprasert W; Kaojarern S
    J Med Assoc Thai; 2007 Jul; 90(7):1467-76. PubMed ID: 17710993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venomous snakebites worldwide with a focus on the Australia-Pacific region: current management and controversies.
    Cheng AC; Currie BJ
    J Intensive Care Med; 2004; 19(5):259-69. PubMed ID: 15358944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could this be snakebite?
    Hawdon GM; Winkel KD
    Aust Fam Physician; 1997 Dec; 26(12):1386-91, 1393-4. PubMed ID: 9470292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Envenoming and antivenom use in Australia.
    White J
    Toxicon; 1998 Nov; 36(11):1483-92. PubMed ID: 9792162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
    Zdenek CN; den Brouw BO; Dashevsky D; Gloria A; Youngman NJ; Watson E; Green P; Hay C; Dunstan N; Allen L; Fry BG
    Toxicol Lett; 2019 Nov; 316():171-182. PubMed ID: 31442586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.